| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |